Tian, Yu-Shi
Mao, Xinhua
Zhou, Yi
Fukuzawa, Kaori
Ikeda, Kenji
Hatabu, Asuka
Article History
Received: 10 January 2025
Accepted: 9 May 2025
First Online: 24 May 2025
Declarations
:
: The research protocol was reviewed and approved by the Ethics Review Committee of the Graduate School of Pharmaceutical Sciences at Osaka University (Yakuhito23-15). The study was conducted in accordance with ethical standards outlined in the Ethical Guidelines for Medical and Health Research Involving Human Subjects (Minister of Health, Labour and Welfare, Japan). Given the nature of the online questionnaire survey, informed consent to participate in the study was obtained from all participants as follows: At the top of the online questionnaire, participants were informed that submitting their responses indicated consent to participate in the study. The survey was anonymous, and results were aggregated to ensure confidentiality. Additionally, the purpose of the study, details of the questions, time required for completion, and measures taken to maintain confidentiality were clearly documented in the online instructions.
: Not applicable.
: The authors declare no competing interests.